Prospective assessment of the frequency of and risk factors for bleeding events in patients treated with cefazolin.

Emmanuelle Gras Yohann Tran Benjamin Kably Agnes Lillo Le Louet Thibaut Caruba Brigitte Sabatier Manon LaunayEliane BillaudDavid M Smadja Nicolas Gendron David Lebeaux

Published in: Infection (2023)

Bleeding events associated with cefazolin treatment are frequent. Close clinical monitoring should be performed for patients treated for endocarditis and/or receiving vitamin K antagonists. Hemostasis work-up could be restricted to these patients.

Keyphrases

end stage renal disease
atrial fibrillation
newly diagnosed
prognostic factors
peritoneal dialysis